microdosing tirzepatide vs semaglutide injection dosage chart chart: complete comparison guide Tirzepatide – Ready Med – TrimRX | Semaglutide vs Tirzepatide:

Obesity Three of the GLP-1 RAs are FDA approved for obesity: liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), and tirzepatide (Mounjaro, Zepbound) (these have separate brands for diabetes and obesity, and we have listed the diabetes brand first)

Ozempic trials focused on diabetes management rather than weight loss as a primary outcome, but the weight loss data from these studies showed significant results

The biological rationale is sound

Safety Considerations and Who This Treatment Applies To GLP-1 therapy is generally safe for hypothyroid patients on stable thyroid replacement, but contraindications include personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2 (MEN2), or severe pancreatitis